Researchers from Rutgers University have identified human gene markers that lead to the development of metastatic prostate cancer or cancer that spreads past the prostate.
Prostate cancer is the second leading cause of cancer-related death in men in the United States, and metastatic prostate cancer has a five-year survival rate of 30%.